Y.J. Ko - Concepedia

Author

Y.J. Ko

Sunnybrook Health Science Centre ORCID

Also Known As

D. Behringer, Ko, Youngjoong, Y. J. Ko, Y. Ko, Y.-J. Ko, Y.J. Ko, Yeo Gyeong Ko, Yoon-Hee Ko, Youngjoong Ko

Publications

402

Citations

H-Index

Concepts

All Affiliations

Sunnybrook Health Science Centre Health Sciences Centre University of Toronto University of Calgary McGill University

About

Y.J. Ko is an author at Sunnybrook Health Science Centre specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	209
2	Health Sciences	4	4	194
3	Gastroenterology	3	3	182
4	Hepatology	2	2	109
5	Diagnostic Sciences	1	1	34

Y.J. Ko

Publications

330

Citations

H-Index

Page 1

	Year	Citations
Cost-Effectiveness of Systemic Therapies for Metastatic Pancreatic Cancer Vincent C. Tam, Y.J. Ko, Nicole Mittmann, Current Oncology	2013	86
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement Paul J. Karanicolas, Peter Metrakos, Kelvin Chan, Current Oncology Surgical OncologyGastroenterologySurgeryPharmacotherapyMetronomic Chemotherapy	2013	75
Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: A single institution experience Moisés Cukier, Andrew J. Smith, Laurent Milot, European Journal of Surgical Oncology Single Institution ExperienceSurgical OncologyNeoadjuvant ChemoradiotherapyGastrointestinal OncologyColorectal Surgery	2012	73
Phase II Study with Gemcitabine in Gallbladder and Biliary Tract Carcinomas<sub>a</sub> J. Mezger, Tilman Sauerbruch, Y.J. Ko, Oncology Research and Treatment Preclinical TherapeuticsSurgical OncologyGastroenterologyPathologyPhase Ii Study	1998	34
Impact of Country-Specific EQ-5D-3L Tariffs on the Economic Value of Systemic Therapies Used in the Treatment of Metastatic Pancreatic Cancer Kelly Lien, Vincent C. Tam, Y.J. Ko, Current Oncology	2015	25
New Multidisciplinary Prostate Bone Metastases Clinic: First of Its Kind in Canada Philiz Goh, Kristin Harris, J. Napolskikh, Current Oncology UrologySurgical OncologyGenitourinary CancerMedicineCancer Management	2007	15
Impact of the Number of Prior Lines of Therapy and Prior Perioperative Chemotherapy in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma: Implications for Trial Design Gregory R. Pond, Joaquim Bellmunt, Jonathan E. Rosenberg, Clinical Genitourinary Cancer UrologyPrior LinesGenitourinary CancerMedicineClinical Trials	2014	12
What Is a Clinically Meaningful Survival Benefit in Refractory Metastatic Colorectal Cancer? Y.J. Ko, Mahmoud Abdelsalam, Petr Kavan, Current Oncology	2019	10

Page 1